Search results
Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of...
WFRV 5 Green Bay· 1 week agoSentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved ...
Novartis Is Tracking Well Above the Industry
GuruFocus.com via Yahoo Finance· 1 week agoSource: GuruFocus Conclusion In our assessment, increased competition in the global cancer therapeutics market from Merck (NYSE:MRK) and
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Morningstar· 1 week agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax ...